Hamilton Lane Advisors LLC Humacyte, Inc. Transaction History
Hamilton Lane Advisors LLC
- $93.6 Million
- Q3 2024
A detailed history of Hamilton Lane Advisors LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Hamilton Lane Advisors LLC holds 21,893 shares of HUMA stock, worth $101,802. This represents 0.13% of its overall portfolio holdings.
Number of Shares
21,893
Previous 21,893
-0.0%
Holding current value
$101,802
Previous $105,000
13.33%
% of portfolio
0.13%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding HUMA
# of Institutions
150Shares Held
35.1MCall Options Held
279KPut Options Held
607K-
Black Rock Inc. New York, NY7.14MShares$33.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.06MShares$23.5 Million0.0% of portfolio
-
State Street Corp Boston, MA4.76MShares$22.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.04MShares$9.49 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$5.89 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $479M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...